Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Lemos, BD AU - Storer, BE AU - Iyer, JG AU - Phillips, JL AU - Bichakjian, CK AU - Fang, LC TI - Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system J2 - J Am Acad Dermatol SP - 751 PY - 2010 VL - 63 SP - 751 ER - TY - ELEC LB - 2. AU - National Cancer Intelligence Network J2 - Rare Skin Cancer in England PY - 2011 ER - TY - JOUR LB - 3. AU - Ma, JE AU - Brewer, JD TI - Merkel cell carcinoma in immunosuppressed patients J2 - Cancers SP - 1328 PY - 2014 VL - 6 SP - 1328 ER - TY - JOUR LB - 4. AU - Koljonen, V AU - Kukko, H AU - Pukkala, E AU - Sankila, R AU - Bohling, T AU - Tukiainen, E TI - Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma J2 - Br J Cancer SP - 1444 PY - 2009 VL - 101 SP - 1444 ER - TY - JOUR LB - 5. AU - Penn, I AU - First, MR TI - Merkel’s cell carcinoma in organ recipients: report of 41 cases J2 - Transplantation SP - 1717 PY - 1999 VL - 68 SP - 1717 ER - TY - JOUR LB - 6. AU - Engels, EA AU - Frisch, M AU - Goedert, JJ AU - Biggar, RJ AU - Miller, RW TI - Merkel cell carcinoma and HIV infection J2 - Lancet SP - 497 PY - 2002 VL - 359 SP - 497 ER - TY - JOUR LB - 7. AU - Hemminki, K AU - Liu, X AU - Ji, J AU - Sundquist, J AU - Sundquist, K TI - Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease J2 - Int J Cancer SP - E326 PY - 2012 VL - 131 SP - E326 ER - TY - JOUR LB - 8. AU - Asgari, MM AU - Sokil, MM AU - Warton, EM AU - Iyer, J AU - Paulson, KG AU - Nghiem, P TI - Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma J2 - JAMA Dermatol SP - 716 PY - 2014 VL - 150 SP - 716 ER - TY - JOUR LB - 9. AU - Fields, RC AU - Busam, KJ AU - Chou, JF AU - Panageas, KS AU - Pulitzer, MP AU - Allen, PJ TI - Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma J2 - Cancer SP - 3311 PY - 2012 VL - 118 SP - 3311 ER - TY - JOUR LB - 10. AU - Feng, H AU - Shuda, M AU - Chang, Y AU - Moore, PS TI - Clonal integration of a polyomavirus in human Merkel cell carcinoma J2 - Science SP - 1096 PY - 2008 VL - 319 SP - 1096 ER - TY - JOUR LB - 11. AU - Chang, Y AU - Moore, PS TI - Merkel cell carcinoma: a virus-induced human cancer J2 - Annu Rev Pathol SP - 123 PY - 2012 VL - 7 SP - 123 ER - TY - JOUR LB - 12. AU - Allen, PJ AU - Bowne, WB AU - Jaques, DP AU - Brennan, MF AU - Busam, K AU - Coit, DG TI - Merkel cell carcinoma: prognosis and treatment of patients from a single institution J2 - J Clin Oncol SP - 2300 PY - 2005 VL - 23 SP - 2300 ER - TY - JOUR LB - 13. AU - Samuel, RJ AU - Matthews, AG AU - Holme, SA TI - Merkel cell carcinoma in Scotland 2000–2010 J2 - Br J Dermatol SP - 1073 PY - 2015 VL - 173 SP - 1073 ER - TY - JOUR LB - 14. AU - Jackson, PC AU - Wallis, K AU - Allgar, V AU - Lind, MJ AU - Stanley, PR TI - Merkel cell carcinoma in East Yorkshire: a case series and literature review of current management J2 - J Plast Reconstr Aesth Surg SP - 667 PY - 2015 VL - 68 SP - 667 ER - TY - JOUR LB - 15. AU - Blythe, JN AU - Macpherson, D AU - Reuther, WJ AU - Ethunandan, M AU - Ilankovan, V AU - Sharma, S TI - Management of early stage cutaneous Merkel cell carcinoma of the head and neck J2 - Br J Oral Maxill Surg SP - 806 PY - 2014 VL - 52 SP - 806 ER - TY - JOUR LB - 16. AU - Lewis, KG AU - Weinstock, MA AU - Weaver, AL AU - Otley, CC TI - Adjuvant local irradiation for Merkel cell carcinoma J2 - Arch Dermatol SP - 693 PY - 2006 VL - 142 SP - 693 ER - TY - JOUR LB - 17. AU - Ghadjar, P AU - Kaanders, JH AU - Poortmans, P AU - Zaucha, R AU - Krengli, M AU - Lagrange, JL TI - The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network J2 - Int J Radiat Oncol Biol Phys SP - e583 PY - 2011 VL - 81 SP - e583 ER - TY - JOUR LB - 18. AU - Parvathaneni, U AU - Iyer, J AU - Nagase, K AU - Parvathaneni, K AU - Nghiem, P TI - The safety and efficacy of primary radiation therapy without upfront surgery for Merkel cell carcinoma J2 - Int J Radiat Oncol Biol Phys SP - S168 PY - 2012 VL - 84 SP - S168 ER - TY - JOUR LB - 19. AU - Pape, E AU - Rezvoy, N AU - Penel, N AU - Salleron, J AU - Martinot, V AU - Guerreschi, P TI - Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients J2 - J Am Acad Dermatol SP - 983 PY - 2011 VL - 65 SP - 983 ER - TY - JOUR LB - 20. AU - Sundaresan, P AU - Hruby, G AU - Hamilton, A AU - Hong, A AU - Boyer, M AU - Chatfield, M AU - Thompson, JF TI - Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma J2 - Clin Oncol (R Coll Radiol) SP - e131 PY - 2012 VL - 24 SP - e131 ER - TY - JOUR LB - 21. AU - Veness, M AU - Foote, M AU - Gebski, V AU - Poulsen, M TI - The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients J2 - Int J Radiat Oncol Biol Phys SP - 703 PY - 2010 VL - 78 SP - 703 ER - TY - JOUR LB - 22. AU - Veness, M AU - Howle, J TI - Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead Hospital experience of 41 patients J2 - Australas J Dermatol SP - 19 PY - 2015 VL - 56 SP - 19 ER - TY - JOUR LB - 23. AU - Harrington, C AU - Kwan, W TI - Outcomes of Merkel cell carcinoma treated with radiotherapy without radical surgical excision J2 - Ann Surg Oncol SP - 3401 PY - 2014 VL - 21 SP - 3401 ER - TY - JOUR LB - 24. AU - Jouary, T AU - Leyral, C AU - Dreno, B AU - Doussau, A AU - Sassolas, B AU - Beylot-Barry, M AU - Groupe de Cancérologie Cutanée of the Société Française de Dermatologie TI - Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study J2 - Ann Oncol SP - 1074 PY - 2012 VL - 23 SP - 1074 ER - TY - JOUR LB - 25. AU - Senchenkov, A AU - Barnes, SA AU - Moran, SL TI - Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities J2 - J Surg Oncol SP - 229 PY - 2007 VL - 95 SP - 229 ER - TY - JOUR LB - 26. AU - Tsang, G AU - O’Brien, P AU - Robertson, R AU - Hamilton, C AU - Wratten, C AU - Denham, J TI - All delays before radiotherapy risk progression of Merkel cell carcinoma J2 - Australas Radiol SP - 371 PY - 2004 VL - 48 SP - 371 ER - TY - GEN LB - 27. AU - National Comprehensive Cancer Network J2 - NCCN Clinical Practice Guidelines in Oncology: Merkel Cell Carcinoma v.1.2009 PY - 2009 ER - TY - JOUR LB - 28. AU - Kachare, SD AU - Wong, JH AU - Vohra, NA AU - Zervos, EE AU - Fitzgerald, TL TI - Sentinel lymph node biopsy is associated with improved survival in Merkel cell carcinoma J2 - Ann Surg Oncol SP - 1624 PY - 2014 VL - 21 SP - 1624 ER - TY - JOUR LB - 29. AU - Fields, RC AU - Busam, KJ AU - Chou, JF AU - Panageas, KS AU - Pulitzer, MP AU - Kraus, DH TI - Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution J2 - Ann Surg Oncol SP - 2529 PY - 2011 VL - 18 SP - 2529 ER - TY - JOUR LB - 30. AU - Sadeghi, R TI - Importance of sentinel node mapping in Merkel cell carcinoma: important new evidence by Tseng et al J2 - Am J Surg SP - 1111 PY - 2015 VL - 209 SP - 1111 ER - TY - JOUR LB - 31. AU - Tseng, J AU - Dhungel, B AU - Mills, JK AU - Diggs, BS AU - Weerasinghe, R AU - Fortino, J AU - Vetto, JT TI - Merkel cell carcinoma: what makes a difference? J2 - Am J Surg SP - 342 PY - 2015 VL - 209 SP - 342 ER - TY - JOUR LB - 32. AU - Beylergil, V AU - Carrasquillo, JA TI - Molecular imaging and therapy of merkel cell carcinoma J2 - Cancers SP - 1020 PY - 2014 VL - 6 SP - 1020 ER - TY - JOUR LB - 33. AU - Hawryluk, EB AU - O’Regan, KN AU - Sheehy, N AU - Guo, Y AU - Dorosario, A AU - Sakellis, CG TI - Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women’s Cancer Center J2 - J Am Acad Dermatol SP - 592 PY - 2013 VL - 68 SP - 592 ER - TY - ELEC LB - 34. AU - Slater, D AU - Walsh, M J2 - Standards and Datasets for Reporting Cancers: Dataset for the Histological Reporting of Primary Cutaneous Merkel Cell Carcinoma and Regional Lymph Nodes PY - 2014 ER - TY - JOUR LB - 35. AU - Durante, M AU - Reppingen, N AU - Held, KD TI - Immunologically augmented cancer treatment using modern radiotherapy J2 - Trends Mol Med SP - 565 PY - 2013 VL - 19 SP - 565 ER - TY - JOUR LB - 36. AU - Angell, H AU - Galon, J TI - From the immune contexture to the immunoscore: the role of prognostic and predictive immune markers in cancer J2 - Curr Opin Immunol SP - 261 PY - 2013 VL - 25 SP - 261 ER - TY - JOUR LB - 37. AU - Paulson, KG AU - Iyer, JG AU - Tegeder, AR AU - Thibodeau, R AU - Schelter, J AU - Koba, S TI - Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival J2 - J Clin Oncol SP - 1539 PY - 2011 VL - 29 SP - 1539 ER - TY - JOUR LB - 38. AU - Paulson, KG AU - Iyer, JG AU - Simonson, WT AU - Blom, A AU - Thibodeau, RM AU - Schmidt, M TI - CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study J2 - Am J Clin Pathol SP - 452 PY - 2014 VL - 142 SP - 452 ER - TY - JOUR LB - 39. AU - Sihto, H AU - Bohling, T AU - Kavola, H AU - Koljonen, V AU - Salmi, M AU - Jalkanen, S AU - Joensuu, H TI - Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study J2 - Clin Cancer Res SP - 2872 PY - 2012 VL - 18 SP - 2872 ER - TY - confproc LB - 40. AU - Pallan, L AU - Hislop, A AU - Birtwhistle, J AU - Blackbourn, D AU - Steven, N TI - Differences in phenotype and function of the immune in Merkel Cell Cancer patients compared with control patient group ER - TY - JOUR LB - 41. AU - Steven, N AU - Lawton, P AU - Poulsen, M TI - Merkel cell carcinoma: current controversies and future directions J2 - Clin Oncol (R Coll Radiol) SP - 789 PY - 2019 VL - 31 SP - 789 ER - TY - JOUR LB - 42. AU - Bichakjian, CK AU - Olencki, T AU - Aasi, SZ AU - Alam, M AU - Andersen, JS AU - Blitzblau, R TI - Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology J2 - J Natl Compr Canc Netw SP - 742 PY - 2018 VL - 16 SP - 742 ER - TY - JOUR LB - 43. AU - Gauci, ML AU - Aristei, C AU - Becker, JC AU - Blom, A AU - Bataille, V AU - Dreno, B AU - European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC) TI - Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – update 2022 J2 - Eur J Cancer SP - 203 PY - 2022 VL - 171 SP - 203 ER - TY - JOUR LB - 44. AU - D’Angelo, SP AU - Lebbé, C AU - Mortier, L AU - Brohl, AS AU - Fazio, N AU - Grob, JJ TI - First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study J2 - J ImmunoTher Cancer SP - e002646 PY - 2021 VL - 9 SP - e002646 ER - TY - JOUR LB - 45. AU - Nghiem, P AU - Bhatia, S AU - Lipson, EJ AU - Sharfman, WH AU - Kudchadkar, RR AU - Brohl, AS TI - Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma J2 - J ImmunoTher Cancer SP - e002478 PY - 2021 VL - 9 SP - e002478 ER - TY - JOUR LB - 46. AU - D’Angelo, SP AU - Russell, J AU - Lebbe, C AU - Chmielowski, B AU - Gambichler, T AU - Grob, JJ TI - Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim analysis of a clinical trial J2 - JAMA Oncol SP - e180077 PY - 2018 VL - 4 SP - e180077 ER - TY - JOUR LB - 47. AU - Nghiem, P AU - Bhatia, S AU - Lipson, EJ AU - Sharfman, WH AU - Kudchadkar, RR AU - Brohl, AS TI - Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy J2 - J Clin Oncol SP - 693 PY - 2019 VL - 37 SP - 693 ER - TY - JOUR LB - 48. AU - Topalian, SL AU - Bhatia, S AU - Amin, A AU - Kudchadkar, RR AU - Sharfman, WH AU - Lebbé, C TI - Neoadjuvant nivolumab for patients with resectable Merkel cell carcinoma in the CheckMate 358 trial J2 - J Clin Oncol SP - 2476 PY - 2020 VL - 38 SP - 2476 ER - TY - JOUR LB - 49. AU - Gunaratne, DA AU - Howle, JR AU - Veness, MJ TI - Definitive radiotherapy for Merkel cell carcinoma confers clinically meaningful in-field locoregional control: a review and analysis of the literature J2 - J Am Acad Dermatol SP - 142 PY - 2017 VL - 77 SP - 142 ER - TY - JOUR LB - 50. AU - Bhatia, S AU - Storer, BE AU - Iyer, JG AU - Moshiri, A AU - Parvathaneni, U AU - Byrd, D TI - Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer Data Base J2 - J Natl Cancer Inst SP - djw042 PY - 2016 VL - 108 SP - djw042 ER - TY - JOUR LB - 51. AU - Tarabadkar, ES AU - Fu, T AU - Lachance, K AU - Hippe, DS AU - Pulliam, T AU - Thomas, H TI - Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: analysis of 188 cases of localized disease and proposed management algorithm J2 - J Am Acad Dermatol SP - 340 PY - 2021 VL - 84 SP - 340 ER - TY - JOUR LB - 52. AU - Gunaratne, DA AU - Howle, JR AU - Veness, MJ TI - Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases J2 - Br J Dermatol SP - 273 PY - 2016 VL - 174 SP - 273 ER - TY - JOUR LB - 53. AU - Yusuf, M AU - Gaskins, J AU - May, ME AU - Mandish, S AU - Wall, W AU - Fisher, W TI - Immune status and the efficacy of adjuvant radiotherapy for patients with localized Merkel cell carcinoma of the head and neck J2 - Clin Transl Oncol SP - 2009 PY - 2020 VL - 22 SP - 2009 ER - TY - JOUR LB - 54. AU - Tseng, YD AU - Nguyen, MH AU - Baker, K AU - Cook, M AU - Redman, M AU - Lachance, K TI - Effect of patient immune status on the efficacy of radiation therapy and recurrence-free survival among 805 patients with Merkel cell carcinoma J2 - Int J Radiat Oncol Biol Phys SP - 330 PY - 2018 VL - 102 SP - 330 ER -